激素替代治疗

  • 网络Hormone replacement therapy;hrt;hormone replacement therapy,HRT;ERT
激素替代治疗激素替代治疗
  1. 结论卵巢早衰是一种多因素引起的疾病,治疗较困难,性激素替代治疗可使临床症状缓解,血清FSH、LH明显降低。

    Conclusion Premature ovarian failure is a disease of multifactors , HRT can improve symptoms and decrease the level of serum FSH and LH .

  2. 激素替代治疗可能增加卵巢癌的危险性

    HRT may increase risk of ovarian cancer

  3. 激素替代治疗非常重要,应该及早开始。

    Hormone replacement therapy is very important and should be instituted early .

  4. 她接受激素替代治疗已经4年了,看起来容光焕发。

    She has been on hormone replacement therapy for four years and looks fantastic .

  5. 28·6%的患者缺乏规范化的激素替代治疗(hormonereplacementtreatment,HRT)。

    28.6 % POF patients lacked standardized hormone replacement treatment ( HRT ) .

  6. 宫颈癌患者血清及组织TGFβ对激素替代治疗的影响

    The Relationship between the TGF β contain of Serum and Expression of Carcinoma in HRT Women with Cervix Cancer

  7. 激素替代治疗对绝经后妇女血清E2、阴道上皮及子宫内膜的影响

    Influence of Hormone Replacement Treatment ( HRT ) on Serum E_2 Vaginal Epithelium and Endometrium Varying with Drug Dosage and Duration of HRT in Postmenopausal Women

  8. 女性激素替代治疗、口服避孕药与女性肺癌关系的Meta分析

    Meta-analysis of the effects on hormone replacement therapy and oral contraceptives associated with female lung cancer risk

  9. 原发性甲减3例,甲状腺激素替代治疗后PRL正常;

    PRL of 3 primary hypothyroidism was normal , after thyroid hormone replacement therapy ;

  10. 本病确切病因尚不清楚,在临床防治中多采用激素替代治疗(HormoneReplacementTherapy,HRT)方法。

    The specific etiological factor is not clear yet . Hormone replacement therapy ( HRT ) is used to prevent and treat this disease clinically .

  11. 结论激素替代治疗可使心血管疾病独立危险因子Lp(a)降低。

    Conclusion Postmenopausal hormone replacement therapy may reduce lipoprotein ( a ), an independent risk factor of coronary artery disease .

  12. 激素替代治疗对心率变异性、QT间期、QT离散度及心律失常发生频率的远期影响

    Long term effects of hormone replacement therapy on heart rate variability , QT interval , QT dispersion and frequencies of arrhythmia

  13. 结论雌二醇控释贴片可作为激素替代治疗(HRT)用于更年期综合征,具有使用方便、副作用小等优点。

    We conclude that estradiol release controlled sticker can be used for hormone replacement therapy with less side effects .

  14. 目的观察激素替代治疗(HRT)对卵巢与宫颈恶性肿瘤预后的影响。

    Object To explore the effects of the hormone replacement therapy on the prognosis of women with ovarian and cervical cancer .

  15. 目的检测绝经期妇女激素替代治疗前后血清瘦素(leptin)水平并初步探讨激素替代治疗对瘦素的调节作用。

    Objective To measure serum leptin levels of menopausal women before and after hormone replacement therapy , and to evaluate the action of hormone replacement therapy in regulating serum leptin levels .

  16. 方法:筛选肥胖(BMI27kg/m2)绝经前后妇女,其BMI相似者(P0.05)并除外接受激素替代治疗个体;

    Methods : We selected pre and post menopausal obese women ( BMI27 kg / m 2 ) whose BMI was matched ( P 0 05 ) . None of them had hormone replacement therapy .

  17. 目的:探讨生育期宫颈和卵巢恶性肿瘤患者手术或放疗后激素替代治疗(HRT)对其外周血性激素的影响。

    Objective : To explore the impact of hormone replacement therapy ( HRT ) on serum sex-hormone of patients with ovarian or cervical cancer after surgery or radiotherapy .

  18. 目的观察激素替代治疗(HRT)绝经妇女的子宫、卵巢和乳腺的声像图表现、绝经期症状及性激素的变化,评价长期小剂量HRT的临床价值。

    Objective To evaluate the clinical value of hormone replacement therapy ( HRT ) by observing uterus , ovary and breast of post ˉ menopausal women with ultrasound .

  19. 流行病学研究表明初潮晚、绝经早可增加白内障发病率,内源性雌激素及激素替代治疗(HormoneReplacementTherapy,HRT)可抑制白内障的形成。

    A number of epidemiologic studies have demonstrated that senior age at menarche and junior age at menopause are associated with an increased incidence of cataract , and that endogenous estrogen or postmenopausal hormone replacement therapy ( HRT ) may prevent cataract development .

  20. 美国癌症研究协会举办的会议上发表的这些研究使得激素替代治疗(HRT)的争论更加复杂,HRT过去主要用于减轻绝经患者的面色潮红和失眠等症状。

    The studies presented at a meeting of the American Association for Cancer Research further complicate the debate about HRT , used to relieve the effects of menopause including hot flashes and insomnia .

  21. 虽然激素替代治疗(HRT)能够有效地增加绝经后妇女的骨密度(BMD),减少骨折的发生,但长期应用导致子宫内膜癌和乳腺癌发病的危险性大大增加。

    Estrogen replacement therapy ( ERT ) is currently considered for increasing the bone mineral density of postmenopausal women effectively , however , has been shown to increase the risk of cancer , such as endometrical and breast cancer .

  22. 研究的最后分析基于106例WHIMS随访研究阶段的妇女形成-即22名既往曾服用激素替代治疗和84名在65岁前未运用激素替代治疗史的妇女。

    The study 's final analysis was based on106 women who developed dementia during the WHIMS follow-up period & 22 of whom reported prior HRT use and84 with no HRT history before age65 years .

  23. 此外,raloxifene在氧应激和β淀粉样蛋白引起的神经损伤中能起保护作用。这种组织选择性拮抗剂/激动剂的特点使它有可能成为一种激素替代治疗的理想药物。

    In addition , raloxifene protects against oxidative stress and β - amyloid-induced neurotoxicity in vitro . The tissue-selective agonist and antagonist actions of raloxifene have led it possible to be an ideal drug in hormone replacement therapy .

  24. 目前常用方法是青春期时给予性激素替代治疗改善第二性征,在有生育需求时给予促性腺激素类似物如人绒毛膜促性腺激素(hCG)和人绝经期促性腺激素(hMG)治疗。

    At present , the frequently used treatment is to give sex steroid replacement therapy improving the secondary sexual characteristics at adolescence and start gonadotropin replacement therapy when fertility is demanded . Human chorionic gonadotropin ( hCG ) and human menopausal gonadotropin ( hMG ) are usually used .

  25. 激素替代治疗和继发性脑卒中的相关性:一项汇总分析

    Association between hormone replacement therapy and subsequent stroke : a meta-analysis

  26. 激素替代治疗与心血管疾病研究新进展

    New Progress in Research of Hormone Replacement Therapy and Cardiovascular Diseases

  27. 78例(27.1%)行激素替代治疗。

    78 cases ( 27.1 % ) received hormone replacement therapy .

  28. 激素替代治疗对激素依赖性肿瘤患者生存的影响

    Influence of hormone replacement therapy on survivor of patients With hormone-dependent tumor

  29. 激素替代治疗甚至有增加血栓性疾病的风险。

    Hormone replacement therapy even increased the risk of thrombosis .

  30. 围绝经期妇女就诊及激素替代治疗态度调查

    Investigation on women 's menopause treatment and attitude toward hormone replacement therapy